Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-08-06 | Mr. Walchirk became our President and Chief Executive Officer in November 2017... held various leadership positions in medical-surgical distribution and manufacturing. |
| 2019-08-02 | Mr. Walchirk previously served as President of U.S. Pharmaceutical at McKesson Corporation from October 2012 to October 2017, where he held responsibility for McKesson's U.S. Pharmaceutical sales, distribution and customer service operations. Mr. Walchirk joined McKesson in April 2001 and held various leadership positions including President of McKesson Specialty Care Solutions and Chief Operating Officer of McKesson U.S. Pharmaceutical. |
| 2020-07-31 | Mark S. Walchirk became our President and Chief Executive Officer in November 2017. Mr. Walchirk previously served as President of U.S. Pharmaceutical at McKesson Corporation from October 2012 to October 2017, where he held responsibility for McKesson’s U.S. Pharmaceutical sales, distribution and customer service operations. Mr. Walchirk joined McKesson in April 2001 and held various leadership positions including President of McKesson Specialty Care Solutions and Chief Operating Officer of McKesson U.S. Pharmaceutical. Before joining McKesson, he spent 13 years in medical-surgical distribution and manufacturing with Baxter Healthcare, Allegiance Healthcare and Encompass Group, holding various leadership positions in sales, marketing, operations and business development. Mr. Walchirk became one of our directors in November 2017. Mr. Walchirk brings strategic and leadership experience, including healthcare services and distribution experience, to our Board. |
| 2021-07-30 | Mr. Walchirk became our President and Chief Executive Officer in November 2017... Mr. Walchirk brings strategic and leadership experience, including healthcare services and distribution experience, to our Board. |
| 2022-07-29 | Mr. Walchirk brings strategic and leadership experience, including healthcare services and distribution experience, to our Board. |
Data sourced from SEC filings. Last updated: 2025-10-11